MedTrace Logo

Patient and Parent Preferences for an On-Body Automated Insulin Delivery System

NCT03534544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 362

Last updated 2021-08-10

No results posted yet for this study

Summary

The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surveys. The results of the study will be used to assist in the design of a new automated insulin delivery system.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Joslin Diabetes Center

    lead OTHER

Principal Investigators

  • Lori Laffel, MD, MPH · Joslin Diabetes Center

  • Stuart Weinzimer, MD · Yale University

  • Eyal Dassau, PhD · Harvard University

Eligibility

Min Age
8 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-23
Primary Completion
2019-12-17
Completion
2019-12-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03534544 on ClinicalTrials.gov